<DOC>
	<DOCNO>NCT02193698</DOCNO>
	<brief_summary>This study investigate efficacy safety Lenalidomide treatment recurrent refractory POEMS ( Crow-Fukase ) syndrome .</brief_summary>
	<brief_title>Efficacy Safety Lenalidomide Treatment Recurrent Refractory POEMS Syndrome Trial</brief_title>
	<detailed_description>This study investigate efficacy safety Lenalidomide treatment recurrent /refractory POEMS ( Crow-Fukase ) syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>POEMS Syndrome</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Patients CrowFukase syndrome ( confirm diagnostic criterion . ) 2 . Recurrent refractory CrowFukase syndrome . 3 . Patients without severe liver renal dysfunction . 4 . Patients without severe neutropenia thrombocytopenia . 5 . Patients without clinically problematic ECG finding 6 . Negative pregnacy test day 1 cycle 1 . 7 . Patients undertake prevention pregnancy , necessary . 8 . Patients write informed consent . 9 . Patients capable ambulatory hospital visit every 4 week . 10 . Patients informed consent registration rule RevMateÂ® . 1 . Patients administer , bortezomib , lenalidomide , melpharan within 4 week prior registration . 2 . Patients steroid treatment ( 10mg/day predonine ) within 2 week prior registration . 3 . Patients administer bevacizumab within 12 week prior registration . 4 . Patients could worsen acutely clinical trial period . 5 . Patients severe complicaitons ( cardiac failure , renal failure liver failure , bleed enterogastric ulcer , ileus , poorly control diabetes . 6 . Patients malignancy . 7 . Female patient pregnant desire childbearing . Males desire fertility . 8 . Patients allergic lenalidomide dexamethasone .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>POEMS syndrome</keyword>
	<keyword>lenalidomide</keyword>
</DOC>